Table 1.
Reported cases of primary pancreatic leiomyosarcoma in the English literature of our review
| Author | Year | Sex/age, year (mean) | Location in pancreas (number) | Pathology (number) | Treatment (number) | Outcome/follow-up, months (number) |
|---|---|---|---|---|---|---|
| Shtamler et al8 | 1988 | Female/31 | Head | DHL | PD+CMT | ANED/14 months |
| Hirabayashi et al9 | 1991 | Male/74 | Head | B-cell lymphoma | DP | AWD |
| Joly et al10 | 1992 | Female/23 | Head | B-cell lymphoma | PD+CMT | DOD |
| Van Beers et al11 | 1993 | 5 males and 3 females/26–77 (58) | Head (5), body and tail (3) | NBL (8) | NA | NA |
| Behrns et al5 | 1994 | 8 males and 4 females/NR | Head (6), body (3), tail (2), whole (1) | DLBCL (7), mixed (2), and small cleaved lymphoma (2) | RT (5), CMT (2), RT+CMT (3), PD (2) | Survival (mean) RT/22 months, CMT/13 months, RT+CMT/26 months |
| Ezzat et al12 | 1996 | 4 males and 1 female/38–51 (43) | Head (4), body and tail (1) | DLBCL (3) and diffuse large B-cell lymphoma (2) | CMT (3), CMT+RT (2) | ANED/21, 24, 26, 84 months (4); AWD/23 months (1) |
| Salvatore et al13 | 2000 | Male/59 | Whole | DLBCL | CMT | NA |
| Nayer et al15 | 2004 | 7 males and 1 female/35–75 (55) | Head (7), body and tail (1) | LBCL (4), follicular lymphoma (1), small lymphocytic lymphoma (1), suspicious (1) | RT+CMT (3), CMT (4), NA (2) | AWD/72 months (1), ANED/2, 5, 6, 7, 72 months (5), NA (2) |
| Volmar et al14 | 2004 | 7 males and 3 females/46–86 (65) | Head (12), body (1), and tail (1) | LBCL (6), FCL (3), and unclassified B-cell lymphoma (1) | CMT | DOD (2), AWD (12) |
| Ji et al16 | 2005 | Male/46 | Head | DLBCL | PD | NA |
| Arcari et al17 | 2005 | 4 males and 1 female/58–71 (65) | Head (5) | Large B-cell (3) and lymphoplasmacytic lymphoma (2) | PD+CMT (2), CMT+RT (2), CMT (1) | ANED/78 months (range 8–160 months) |
| Lee et al18 | 2006 | Female/61 | Head | B-cell lymphoma | DP+CMT | ANED |
| Wang et al19 | 2006 | Male/49 | Head | Burkitt lymphoma | DOD | |
| Lin et al4 | 2006 | 5 males and 1 female/16–65 (45) | Head (3), body and tail (2), whole (1) | B-cell lymphoma (3) and NBL (3) | PD+CMT (2), CMT+RT (1), CMT (2) | DOD/0.5, 37, 49 months (3), ANED (1), NA (2) |
| Basu et al20 | 2007 | Male/42 | Body | DLBCL | CMT+RT | ANED |
| Saif et al21 | 2007 | Female/57 | Whole | LBCL | CMT | NA |
| Liakakos et al22 | 2008 | Male/65 | Head | NBL | PD+CMT | ANED/21 months |
| Hashimoto et al23 | 2008 | Male/50 | Head | DLBCL | CMT+PD | ANED/7 months |
| Sağlam et al24 | 2009 | Male/20 | Burkitt lymphoma | CMT | DOD | |
| Bautista et al25 | 2009 | Male/13 | Tail | NBL | CMT | ANED/15 months |
| Haji et al26 | 2009 | Not mention | Head (2) and tail (1) | DLBCL | CMT+RT (2) and PD+CMT (1) | NA |
| Sugishita et al27 | 2010 | Male/16 | Head | DBCL | PD+CMT | ANED/48 months |
| Abe et al28 | 2010 | Male/56 | Head | B-cell lymphoma | PD+CMT | NA |
| Alexander et al29 | 2011 | Male/61 | Head | DLBCL | PD+CMT | ANED/18 months |
| Anderloni et al30 | 2015 | Female/33 | Head | NBL | CMT | ANED/18 months |
| Fukuba et al31 | 2016 | Female/60 | Head | DLBCL | CMT | NA |
Abbreviations: ANED, alive and no evidence of disease; AWD, alive with disease; cm, centimeters; CMT, chemotherapy; DHL, diffuse histiocytic lymphoma; DLBCL, diffuse large B cell lymphoma; DOD, died of disease; DP, distal pancreatectomy; FCL, follicular cell lymphoma; LBCL, large B cell lymphoma; n, number of cases; NA, not available; NBL, non-Hodgkin B lymphomas; PD, pancreatico-duodenectomy; RT, radiotherapy.